Matthew B. Francis

Matthew B. Francis

Founder at Catena Biosciences, Inc.

4 connections
Commercial Services

Profile

Matthew B.
Francis has founded Catena Biosciences, Inc. in 2020 and currently holds the position of Director & Chief Science Advisor.

Matthew B. Francis active positions

CompaniesPositionStart
Catena Biosciences, Inc.
Logo Catena Biosciences, Inc.

Catena Biosciences, Inc.

Miscellaneous Commercial ServicesCommercial Services

Catena Biosciences, Inc. is an American biotech company that was founded in May 2021. The company is based in El Cerrito, CA. The company is based on technology developed in the Doudna and Francis labs at the University of California, Berkeley. Catena Biosciences' patented technology, called the Catenase platform, allows the construction of biomolecules that are currently unobtainable using modern manufacturing techniques. The platform has applications across multiple therapeutic areas, with an initial focus in oncology. The company is the recipient of an NIH SBIR grant and the American Cancer Society's BrightEdge Golden Ticket at UC's Bakar Labs. The company was founded in 2020 by Marco Lobba, Gregorio Guillen, Matthew B. Francis. Marco Lobba has been the CEO since 2020.

 Founder 16/11/2020
All active positions of Matthew B. Francis

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Matthew B. Francis's experience

Connections

4

1st degree connections

1

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies1
Catena Biosciences, Inc.
Logo Catena Biosciences, Inc.

Catena Biosciences, Inc.

Miscellaneous Commercial ServicesCommercial Services

Catena Biosciences, Inc. is an American biotech company that was founded in May 2021. The company is based in El Cerrito, CA. The company is based on technology developed in the Doudna and Francis labs at the University of California, Berkeley. Catena Biosciences' patented technology, called the Catenase platform, allows the construction of biomolecules that are currently unobtainable using modern manufacturing techniques. The platform has applications across multiple therapeutic areas, with an initial focus in oncology. The company is the recipient of an NIH SBIR grant and the American Cancer Society's BrightEdge Golden Ticket at UC's Bakar Labs. The company was founded in 2020 by Marco Lobba, Gregorio Guillen, Matthew B. Francis. Marco Lobba has been the CEO since 2020.

Commercial Services

See company connections
  1. Stock Market
  2. Insiders
  3. Matthew B. Francis